Target Name: LOC105377102
NCBI ID: G105377102
Review Report on LOC105377102 Target / Biomarker Content of Review Report on LOC105377102 Target / Biomarker
LOC105377102
Other Name(s): uncharacterized LOC105377102 | Uncharacterized LOC105377102

A Potential Drug Target and Biomarker: LOC105377102

LOC105377102 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and has been shown to play a crucial role in the development and progression of various diseases, including cancer. In this article, we will explore the biology of LOC105377102 and its potential as a drug target and biomarker.

Biology of LOC105377102

LOC105377102 is a non-coding RNA molecule that is expressed in a variety of tissues and cells throughout the body. It is a key regulator of the cell cycle and has been shown to play a crucial role in the development and progression of various diseases, including cancer.

One of the most significant functions of LOC105377102 is its role as a regulator of the cell cycle. The cell cycle is the process by which a cell grows, replicates its DNA, and divides. LOC105377102 is shown to regulate the length of S-phase, which is the stage of the cell cycle where the DNA is replicated. This regulation is critical for the proper functioning of the cell and is implicated in the development and progression of various diseases, including cancer.

Another function of LOC105377102 is its role as a potential drug target. LOC105377102 has been shown to interact with various protein molecules, including the oncogene retinoblastoma gene (Rb) and the tumor suppressor protein p53. These interactions suggest that LOC105377102 may be a useful target for small molecules or other therapeutic compounds that can modulate its activity.

In addition to its role as a regulator of the cell cycle, LOC105377102 has also been shown to serve as a potential biomarker for the diagnosis and prognosis of various diseases. For example, LOC105377102 has been shown to be downregulated in various types of cancer, including breast, ovarian, and prostate cancer. This downregulation is associated with the development and progression of these diseases, and may be a useful biomarker for the diagnosis and prognosis of these conditions.

Potential Therapeutic Applications

The potential therapeutic applications for LOC105377102 are vast and varied. As a drug target, LOC105377102 may be the target of small molecules or other therapeutic compounds that can modulate its activity. This could lead to the development of new treatments for a variety of diseases, including cancer.

In addition to its potential as a drug target, LOC105377102 may also be a useful biomarker for the diagnosis and prognosis of various diseases. Its downregulation in various types of cancer, as well as its regulation of the cell cycle, suggest that it may be a useful biomarker for the diagnosis and prognosis of these conditions.

Conclusion

LOC105377102 is a non-coding RNA molecule that has been shown to play a crucial role in the development and progression of various diseases, including cancer. Its regulation of the cell cycle and its potential as a drug target and biomarker make it an attractive target for therapeutic development. Further research is needed to fully understand the biology of LOC105377102 and its potential as a therapeutic agent.

Protein Name: Uncharacterized LOC105377102

The "LOC105377102 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377102 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304 | LOC105377306 | LOC105377313 | LOC105377323 | LOC105377329 | LOC105377347 | LOC105377352 | LOC105377363 | LOC105377364 | LOC105377369 | LOC105377374 | LOC105377378 | LOC105377448 | LOC105377461 | LOC105377462 | LOC105377481 | LOC105377483 | LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643 | LOC105377646 | LOC105377662 | LOC105377666 | LOC105377683 | LOC105377699 | LOC105377700 | LOC105377714 | LOC105377715 | LOC105377721 | LOC105377727 | LOC105377730 | LOC105377732 | LOC105377739 | LOC105377778 | LOC105377785 | LOC105377795 | LOC105377806 | LOC105377809 | LOC105377824 | LOC105377844 | LOC105377845 | LOC105377858 | LOC105377862 | LOC105377864 | LOC105377865 | LOC105377871 | LOC105377876 | LOC105377877 | LOC105377882 | LOC105377891 | LOC105377913 | LOC105377920 | LOC105377923 | LOC105377924 | LOC105377927 | LOC105377941 | LOC105377968 | LOC105377979 | LOC105377981 | LOC105377989 | LOC105378009 | LOC105378010 | LOC105378011 | LOC105378019